IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PRISCIANDARO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.971
NA - Nord America 1.019
AS - Asia 654
SA - Sud America 16
OC - Oceania 13
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.677
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 1.108
US - Stati Uniti d'America 992
CN - Cina 340
GB - Regno Unito 243
IT - Italia 215
SE - Svezia 174
IN - India 103
SG - Singapore 80
IE - Irlanda 62
DK - Danimarca 32
JP - Giappone 31
FR - Francia 28
CA - Canada 25
ES - Italia 25
HK - Hong Kong 23
ID - Indonesia 21
UA - Ucraina 15
AU - Australia 12
BE - Belgio 12
BR - Brasile 11
NL - Olanda 11
TR - Turchia 11
FI - Finlandia 10
VN - Vietnam 10
KR - Corea 9
NO - Norvegia 7
RU - Federazione Russa 7
CH - Svizzera 6
TW - Taiwan 5
PH - Filippine 4
RO - Romania 4
SA - Arabia Saudita 4
CO - Colombia 3
GR - Grecia 3
MY - Malesia 3
UZ - Uzbekistan 3
IR - Iran 2
MK - Macedonia 2
MX - Messico 2
PK - Pakistan 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
AP - ???statistics.table.value.countryCode.AP??? 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HU - Ungheria 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 3.677
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.018
Chandler 211
Southend 205
Ashburn 87
Milan 74
Fairfield 72
Dublin 57
Beijing 55
Wilmington 55
Ann Arbor 54
Princeton 52
Singapore 46
Woodbridge 40
Shanghai 36
Houston 35
Dearborn 29
Phoenix 28
Seattle 28
Bengaluru 26
Nanjing 24
Cambridge 23
Grafing 23
Jinan 20
Des Moines 18
Jakarta 17
New York 17
Redwood City 17
Pune 15
Toronto 15
Hyderabad 13
Hangzhou 12
Brussels 10
Central District 10
Helsinki 10
Berlin 9
Guangzhou 9
Los Angeles 9
Shenyang 9
Falls Church 8
Fremont 8
Hebei 8
London 8
Mumbai 8
Seoul 8
São Paulo 8
Tokyo 8
Hong Kong 7
Oslo 7
Rome 7
Turin 7
Upper Marlboro 6
Wuhan 6
Bühl 5
Changsha 5
Chengdu 5
Fuzhou 5
Madrid 5
Mappano 5
Nanchang 5
Ningbo 5
Nuremberg 5
Rho 5
Rotterdam 5
San Diego 5
Cagliari 4
Calgary 4
Kyoto 4
New Delhi 4
Norwalk 4
Patna 4
Ranchi 4
Rostov-on-don 4
San Francisco 4
Tianjin 4
Zhengzhou 4
Andover 3
Baotou 3
Boardman 3
Bucharest 3
Córdoba 3
Duncan 3
Hamburg 3
Hefei 3
Jiaxing 3
Mancherial 3
Málaga 3
Newcastle 3
Osimo 3
Ourense 3
Riyadh 3
Silver Spring 3
Smyrna 3
Suzhou 3
Taipei 3
Taizhou 3
Alcamo 2
Ankara 2
Athens 2
Bangkok 2
Bergamo 2
Totale 2.766
Salva come PNG Salva come JPEG
Nome #
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 377
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 225
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer 194
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study 187
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? 158
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 158
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 156
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 153
The landscape of actionable gene fusions in colorectal cancer 148
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 142
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 133
TREMELIMUMAB AND DURVALUMAB COMBINATION FOR THE NON-OPERATIVE MANAGEMENT OF MICROSATELLITE INSTABILITY HIGH RESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER: RESULTS OF COHORT 1 OF THE MULTICENTRE, SINGLE-ARM, MULTI-COHORT, PHASE II INFINITY STUDY 130
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 129
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 121
Tremelimumab and durvalumab combination for the non-operative management (NOM) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer : The multicentre, single-arm, multi-cohort, phase II INFINITY study 118
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients : the AMNESIA Case-Control Study 117
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram 110
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients : A Multi-institutional Analysis 105
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected 103
Personalized therapeutic strategies in HER2-driven gastric cancer 100
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 90
Differential histopathologicparameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials 86
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials. 84
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 75
Recent Advances in the Management of Typical and Atypical Lung Carcinoids 72
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 71
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 70
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 65
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 59
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience 51
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 30
Totale 3.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020326 42 12 7 40 17 34 24 13 81 40 7 9
2020/2021437 13 22 31 24 31 39 15 46 85 45 41 45
2021/2022646 51 46 49 45 31 39 30 43 67 74 32 139
2022/2023668 75 102 53 71 50 120 19 29 67 13 57 12
2023/20241.461 25 24 59 55 91 51 235 199 98 194 218 212
2024/2025111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 3.817